David H. Gutmann
@dhgutmann.bsky.social
Neurofibromatosis Researcher, Physician, Educator, Mentor. Passionate about my grandchildren and jazz music.
Reposted by David H. Gutmann
For the first time ever, the Michigan Men’s and Women’s Basketball teams are both in the Top-10 of their respective AP Polls at the same time: https://www.maizenbrew.com/michigan-mens-basketball/97996/ap-poll-michigan-basketball-dusty-may-kim-barnes-arico
Michigan Men’s, Women’s Basketball in AP Top-10 at same time for first time ever
For the first time ever, the Michigan Men’s and Women’s Basketball teams are both in the Top-10 of their respective AP Polls at the same time:
www.maizenbrew.com
November 17, 2025 at 6:28 PM
For the first time ever, the Michigan Men’s and Women’s Basketball teams are both in the Top-10 of their respective AP Polls at the same time: https://www.maizenbrew.com/michigan-mens-basketball/97996/ap-poll-michigan-basketball-dusty-may-kim-barnes-arico
Reposted by David H. Gutmann
HUGE thanks to the nearly 200 volunteers who helped us plant hundreds of trees in Forest Park Sunday. You're helping restore and sustain #ForestParkForever
November 3, 2025 at 10:25 PM
HUGE thanks to the nearly 200 volunteers who helped us plant hundreds of trees in Forest Park Sunday. You're helping restore and sustain #ForestParkForever
Reposted by David H. Gutmann
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of study being slashed by the US government
go.nature.com/47hn0n5
go.nature.com/47hn0n5
7 basic science discoveries that changed the world
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of study being slashed by the US government.
go.nature.com
November 1, 2025 at 5:39 PM
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of study being slashed by the US government
go.nature.com/47hn0n5
go.nature.com/47hn0n5
Reposted by David H. Gutmann
Michigan Hockey swept Notre Dame this weekend to move to 9-1 overall on the season: https://www.maizenbrew.com/michigan-hockey/96403/michigan-wolverines-ice-hockey-2025-notre-dame-fighting-irish-tj-hughes-will-horcoff-aidan-park
November 2, 2025 at 11:07 AM
Michigan Hockey swept Notre Dame this weekend to move to 9-1 overall on the season: https://www.maizenbrew.com/michigan-hockey/96403/michigan-wolverines-ice-hockey-2025-notre-dame-fighting-irish-tj-hughes-will-horcoff-aidan-park
Reposted by David H. Gutmann
The deadline to submit to our Special Issue 'In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery' is tomorrow.🚨
We look forward to receiving your next submission for this exciting special issue!
#OpenAccess
bit.ly/4h1092r
We look forward to receiving your next submission for this exciting special issue!
#OpenAccess
bit.ly/4h1092r
November 2, 2025 at 11:13 AM
The deadline to submit to our Special Issue 'In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery' is tomorrow.🚨
We look forward to receiving your next submission for this exciting special issue!
#OpenAccess
bit.ly/4h1092r
We look forward to receiving your next submission for this exciting special issue!
#OpenAccess
bit.ly/4h1092r
Reposted by David H. Gutmann
Wishing you a boo-tiful Halloween from the lab! 🧪🎃 May your experiments work and your candy be plentiful. 👻
November 1, 2025 at 1:27 PM
Wishing you a boo-tiful Halloween from the lab! 🧪🎃 May your experiments work and your candy be plentiful. 👻
Reposted by David H. Gutmann
Save the date and register for abstract updates for @dmmjournal.bsky.social's 2026 Journal Meeting. 'Innovative Preclinical Models for Pediatric Cancer Research'. biologists.com/meetings/dmm... #DMM2026cancer
October 31, 2025 at 8:01 AM
Save the date and register for abstract updates for @dmmjournal.bsky.social's 2026 Journal Meeting. 'Innovative Preclinical Models for Pediatric Cancer Research'. biologists.com/meetings/dmm... #DMM2026cancer
Reposted by David H. Gutmann
A new patent, based on work from Corina Anastasaki, PhD, introduces a revolutionary treatment for NF1 neurofibromas and optic gliomas using anti-seizure medicine, lamotrigine. A clinical trial for NF1 optic pathway glioma is under review.
Read more: https://bit.ly/45DHG7N
Read more: https://bit.ly/45DHG7N
August 27, 2025 at 12:52 PM
A new patent, based on work from Corina Anastasaki, PhD, introduces a revolutionary treatment for NF1 neurofibromas and optic gliomas using anti-seizure medicine, lamotrigine. A clinical trial for NF1 optic pathway glioma is under review.
Read more: https://bit.ly/45DHG7N
Read more: https://bit.ly/45DHG7N
Come join us for postdoc training at WashU: postdoc.wustl.edu/prospective-...
PASSPoRT to WashU | Office of Postdoctoral Affairs | Washington University in St. Louis
Pathways to Advanced Scientific Skills through Postdoctoral Research Training (PASSPoRT) Thank you for considering WashU for your postdoctoral resea...
postdoc.wustl.edu
October 28, 2025 at 5:05 PM
Come join us for postdoc training at WashU: postdoc.wustl.edu/prospective-...
Reposted by David H. Gutmann
Last Friday,we welcomed our friends from Forward Strides 4NF,an amazing family-founded charity that brings awareness and support to the NF center with their fundraising opportunities,like the fun annual family walk you shouldn't miss! We are grateful for their endorsement and opportunity to connect💙
October 27, 2025 at 3:35 PM
Last Friday,we welcomed our friends from Forward Strides 4NF,an amazing family-founded charity that brings awareness and support to the NF center with their fundraising opportunities,like the fun annual family walk you shouldn't miss! We are grateful for their endorsement and opportunity to connect💙
Another amazing CABIN meeting in the books. Thank you to @cshlbanbury.bsky.social and #pennysflight.
October 24, 2025 at 9:29 PM
Another amazing CABIN meeting in the books. Thank you to @cshlbanbury.bsky.social and #pennysflight.
Reposted by David H. Gutmann
Congratulations to winners of The Brain Prize 2025!
Professors @michellemonje.bsky.social, @stanfordmedicine.bsky.social and @hhmi.org Investigator, and Frank Winkler, Heidelberg University Hospital, have pioneered the field of Cancer Neuroscience.
Learn more: brainprize.org/winners/canc...
Professors @michellemonje.bsky.social, @stanfordmedicine.bsky.social and @hhmi.org Investigator, and Frank Winkler, Heidelberg University Hospital, have pioneered the field of Cancer Neuroscience.
Learn more: brainprize.org/winners/canc...
March 5, 2025 at 3:37 PM
Congratulations to winners of The Brain Prize 2025!
Professors @michellemonje.bsky.social, @stanfordmedicine.bsky.social and @hhmi.org Investigator, and Frank Winkler, Heidelberg University Hospital, have pioneered the field of Cancer Neuroscience.
Learn more: brainprize.org/winners/canc...
Professors @michellemonje.bsky.social, @stanfordmedicine.bsky.social and @hhmi.org Investigator, and Frank Winkler, Heidelberg University Hospital, have pioneered the field of Cancer Neuroscience.
Learn more: brainprize.org/winners/canc...
Reposted by David H. Gutmann
“I was advised that having multiple children would detract from my scientific career. But I actually think that it has greatly benefited it.” Prof. @michellemonje.bsky.social, Neurology and Neurological Sciences at Stanford University, #BrainPrize2025.
#Neuroscience
youtu.be/f7sbSuWie5A?...
#Neuroscience
youtu.be/f7sbSuWie5A?...
Balancing a career in science and personal life
YouTube video by BrainPrize
youtu.be
October 21, 2025 at 9:18 AM
“I was advised that having multiple children would detract from my scientific career. But I actually think that it has greatly benefited it.” Prof. @michellemonje.bsky.social, Neurology and Neurological Sciences at Stanford University, #BrainPrize2025.
#Neuroscience
youtu.be/f7sbSuWie5A?...
#Neuroscience
youtu.be/f7sbSuWie5A?...
A beautiful end to a second amazing day of Cognition and Behavior in NF1 at @cshlbanbury.bsky.social
October 22, 2025 at 2:12 AM
A beautiful end to a second amazing day of Cognition and Behavior in NF1 at @cshlbanbury.bsky.social
Reposted by David H. Gutmann
Now online in Cancer Discovery @aacrjournals.bsky.social: Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression - by Daniel Azorín, Dirk Hoffmann, @winklerlab.bsky.social, and colleagues doi.org/10.1158/2159...
October 14, 2025 at 12:00 PM
Now online in Cancer Discovery @aacrjournals.bsky.social: Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression - by Daniel Azorín, Dirk Hoffmann, @winklerlab.bsky.social, and colleagues doi.org/10.1158/2159...
Reposted by David H. Gutmann
#Glioblastoma cells don’t just grow — they extend tumor microtubes that let them invade the brain 🧠 and link into multicellular networks that resist therapy ☢️.
We developed a strategy to inhibit these TMs — and make these cells vulnerable to therapy ☠️.
This study is now online @Cancer Discovery
We developed a strategy to inhibit these TMs — and make these cells vulnerable to therapy ☠️.
This study is now online @Cancer Discovery
October 9, 2025 at 10:07 PM
#Glioblastoma cells don’t just grow — they extend tumor microtubes that let them invade the brain 🧠 and link into multicellular networks that resist therapy ☢️.
We developed a strategy to inhibit these TMs — and make these cells vulnerable to therapy ☠️.
This study is now online @Cancer Discovery
We developed a strategy to inhibit these TMs — and make these cells vulnerable to therapy ☠️.
This study is now online @Cancer Discovery
Reposted by David H. Gutmann
As part of the call for applications below, the Heidelberg/Mannheim site is offering four clinician scientist/postdoc positions in the field of neuro-oncology in the departements of @wickwolfgang.bsky.social and @michael-platten.bsky.social. For applications use the link below.
🚨 Call for Applications: The Hertie Network of Excellence in Clinical Neuroscience (Berlin, Bonn, Hamburg, Heidelberg/Mannheim, Munich, Tübingen) offers up to 4 postdoc/clinician scientist positions per site. Apply by Oct 31! Details 👉 www.hertie-neuroscience-hamburg.de #HertieNetwork #Jobs
Hertie Neuroscience Hamburg
www.hertie-neuroscience-hamburg.de
October 6, 2025 at 10:10 AM
As part of the call for applications below, the Heidelberg/Mannheim site is offering four clinician scientist/postdoc positions in the field of neuro-oncology in the departements of @wickwolfgang.bsky.social and @michael-platten.bsky.social. For applications use the link below.
Reposted by David H. Gutmann
The 2025 Nobel Prize in Physiology or Medicine was awarded jointly to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.” This Collection celebrates the award and recognizes the winners’ achievements. #medsky 🧪
Nobel Prize in Physiology or Medicine 2025
The 2025 Nobel Prize in Physiology or Medicine has been awarded jointly to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries ...
go.nature.com
October 6, 2025 at 7:17 PM
The 2025 Nobel Prize in Physiology or Medicine was awarded jointly to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.” This Collection celebrates the award and recognizes the winners’ achievements. #medsky 🧪
Reposted by David H. Gutmann
Excited to share our latest work in Neuro-Oncology Advances! 🥳 After comparing several potential therapies, we identified lamotrigine as a promising therapy for NF1 optic glioma, showing both tumor reduction and vision protection. Check out the work of our great team!
Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation
AbstractBackground. Authenticated preclinical brain tumor models provide unprecedented opportunities to evaluate next-generation treatments. However, some
academic.oup.com
October 5, 2025 at 11:21 PM
Excited to share our latest work in Neuro-Oncology Advances! 🥳 After comparing several potential therapies, we identified lamotrigine as a promising therapy for NF1 optic glioma, showing both tumor reduction and vision protection. Check out the work of our great team!
The amazing Ms. Mary Stallings at @jazzstlouis.bsky.social. Absolutely wonderful!
October 4, 2025 at 11:37 PM
The amazing Ms. Mary Stallings at @jazzstlouis.bsky.social. Absolutely wonderful!
Reposted by David H. Gutmann
Happy to share the review out in @cp-cellreports.bsky.social
Thanks to amazing Sebastien Talbot and Alexander Birbrair
www.sciencedirect.com/science/arti...
Thanks to amazing Sebastien Talbot and Alexander Birbrair
www.sciencedirect.com/science/arti...
Next-gen tools in cancer neuroscience
The emerging field of cancer neuroscience is rapidly evolving, driven by novel technologies and tools. These include advances in single-cell and spati…
www.sciencedirect.com
September 23, 2025 at 10:52 AM
Happy to share the review out in @cp-cellreports.bsky.social
Thanks to amazing Sebastien Talbot and Alexander Birbrair
www.sciencedirect.com/science/arti...
Thanks to amazing Sebastien Talbot and Alexander Birbrair
www.sciencedirect.com/science/arti...
Reposted by David H. Gutmann
We are still welcoming submissions for our exciting special issue on #InVitroModels of #HumanDisease.
We're looking forward to receiving your next paper by 3 November 2025.
Editors:
@vivianlilab.bsky.social, @ausmith.bsky.social & Joseph Wu
#OpenAccess #DiseaseModelling
#CallforPapers
We're looking forward to receiving your next paper by 3 November 2025.
Editors:
@vivianlilab.bsky.social, @ausmith.bsky.social & Joseph Wu
#OpenAccess #DiseaseModelling
#CallforPapers
September 24, 2025 at 8:46 AM
We are still welcoming submissions for our exciting special issue on #InVitroModels of #HumanDisease.
We're looking forward to receiving your next paper by 3 November 2025.
Editors:
@vivianlilab.bsky.social, @ausmith.bsky.social & Joseph Wu
#OpenAccess #DiseaseModelling
#CallforPapers
We're looking forward to receiving your next paper by 3 November 2025.
Editors:
@vivianlilab.bsky.social, @ausmith.bsky.social & Joseph Wu
#OpenAccess #DiseaseModelling
#CallforPapers
Reposted by David H. Gutmann
Congrats to CSHL's @jborniger.bsky.social and team NEUROIMPACT on making the @cancergrand.bsky.social finals! Their research, showing how the nervous system detects and responds to cancer, could point to new ways of treating the deadly disease. #CancerNeuroscience www.cshl.edu/borniger-rea...
Borniger reaches Cancer Grand Challenges finals | Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory (CSHL) Assistant Professor Jeremy Borniger has been selected for the final stages of a Cancer Grand Challenges research initiative as part of team NEUROIMPACT. The team s...
www.cshl.edu
September 24, 2025 at 5:14 PM
Congrats to CSHL's @jborniger.bsky.social and team NEUROIMPACT on making the @cancergrand.bsky.social finals! Their research, showing how the nervous system detects and responds to cancer, could point to new ways of treating the deadly disease. #CancerNeuroscience www.cshl.edu/borniger-rea...
